arrow
F

Floriana Nappo

Veneto Institute of Oncology IOV-IRCCS
H指数:12
被引数:727

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Zanidatamab vs trastuzumab with or without PD-1 blockade in HER2-positive metastatic gastric cancer: a reconstructed patient-level pooled analysis

赞尼达他马 vs 曲妥珠单抗联合或不联合PD-1阻断剂在HER2阳性转移性胃癌中的比较:一项重建的患者水平合并分析

2026-07-140
OAAI
Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO

曲美木单抗和度伐利尤单抗作为微卫星不稳定性高、可切除的胃或胃食管结合部腺癌患者的新辅助治疗或非手术治疗策略:GONO开展的INFINITY研究

2025-03-018
PRE
Multicentre, multi-cohort, single-arm phase II trial of tremelimumab and durvalumab as neoadjuvant or definitive treatment of patients (pts) with microsatellite instabilityhigh (MSI) resectable gastric or gastroesophageal junction adenocarcinoma (GAC/GEJAC): The INFINITY study
2024-06-010
PRE
Switch maintenance with ramucirumab plus paclitaxel versus continuation of oxaliplatin-based chemotherapy in advanced HER2-negative gastric or gastroesophageal junction (GEJ) cancer: Final results and key biomarkers of the ARMANI phase III trial
2024-06-010
PRE
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells

具有印戒/低粘性细胞的胰腺导管腺癌的临床和基因组特征

2023-09-016
PRE
Concordance of microsatellite instability and mismatch repair status in paired biopsies and surgical specimens of resectable gastroesophageal adenocarcinoma: time for a call to action
2023-06-292
PRE
Bone metastases are associated with worse prognosis in patients affected by metastatic colorectal cancer treated with doublet or triplet chemotherapy plus bevacizumab: a subanalysis of the TRIBE and TRIBE2 trials
2022-12-012
OAAI
The oncological multidimensional prognostic index is a promising decision-making tool: A real-world analysis in older patients with metastatic colorectal cancer
2022-12-015
PRE
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma (vol 171, pg 232, 2022)
2022-12-010
OA
Simultaneous care in oncology: Assessment of benefit in relation to symptoms, sex, and age in 753 patients

肿瘤学的同时护理: 评估753患者的症状,性别和年龄相关的益处

2022-10-147
OAAI
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma
2022-08-0113
PRE
Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas

CLDN18蛋白表达与进展期胃癌及胃食管交界处腺癌临床病理特征及预后的相关性

2021-10-2680
OAAI
KRAS G12C Metastatic Colorectal Cancer: Specific Features of a New Emerging Target Population

KRAS G12C转移性结直肠癌: 新出现的目标人群的特定特征

2020-09-0146
PREAI